Cost-effectiveness of recombinant tissue-type plasminogen activator for acute ischaemic stroke with unknown time of onset: a Markov modelling analysis from the Chinese and US perspectives.
BMJ Open
; 12(11): e065133, 2022 11 14.
Article
in En
| MEDLINE
| ID: mdl-36375982
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Ischemia
/
Stroke
/
Ischemic Stroke
Type of study:
Clinical_trials
/
Health_economic_evaluation
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Humans
Language:
En
Journal:
BMJ Open
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
Reino Unido